Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)

drugsDecember 18, 2018

Tag: FDA , Motegrity , CIC , Shire

PharmaSources Customer Service